Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate
- PMID: 21597989
- PMCID: PMC3210368
- DOI: 10.1007/s00213-011-2345-x
Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate
Abstract
Rationale: The basal ganglia play an important role in motor control, which is dependent on dopaminergic input. Preparation of a motor response has been associated with dopamine release in the basal ganglia, and response readiness may therefore serve as a pharmacodynamic marker of dopamine activity.
Methods: We measured response readiness using the amplitude of the contingent negative variation (CNV), a slow negative shift in the electroencephalogram. The CNV is evoked in a paradigm in which a warning stimulus (S1) signals the occurrence of the imperative stimulus (S2) 4 s later, to which the participant has to respond. CNV was assessed in healthy volunteers after administration of placebo or 10, 20 or 40 mg of methylphenidate, a catecholamine re-uptake blocker which primarily enhances the synaptic concentration of dopamine and to a lesser extent also noradrenaline. In addition, participants filled out two visual analogue scales measuring subjective ratings of mood and alertness: Profile of Mood States and Bond and Lader.
Results: Methylphenidate dose dependently increased CNV amplitude and decreased reaction times. Furthermore, participants reported improved mood, feeling more alert, vigorous and content and less angry and tired after methylphenidate.
Conclusions: These results indicate that dopamine availability increases response readiness as measured by the CNV paradigm. The CNV appears to be a good candidate biomarker for assessing changes in dopaminergic function by treatments that either directly or indirectly target the dopaminergic system.
Figures


Similar articles
-
Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.J Neurochem. 2011 May;117(3):470-8. doi: 10.1111/j.1471-4159.2011.07215.x. Epub 2011 Mar 15. J Neurochem. 2011. PMID: 21323925
-
The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate.J Neurol Sci. 2012 Sep 15;320(1-2):121-6. doi: 10.1016/j.jns.2012.07.015. Epub 2012 Jul 22. J Neurol Sci. 2012. PMID: 22824349 Clinical Trial.
-
Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers.Psychopharmacology (Berl). 2012 Jun;221(4):611-9. doi: 10.1007/s00213-011-2605-9. Epub 2011 Dec 15. Psychopharmacology (Berl). 2012. PMID: 22169884 Free PMC article. Clinical Trial.
-
The system-neurophysiological basis for how methylphenidate modulates perceptual-attentional conflicts during auditory processing.Hum Brain Mapp. 2018 Dec;39(12):5050-5061. doi: 10.1002/hbm.24344. Epub 2018 Aug 22. Hum Brain Mapp. 2018. PMID: 30133058 Free PMC article.
-
Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.Eur Neuropsychopharmacol. 2002 Dec;12(6):557-66. doi: 10.1016/s0924-977x(02)00104-9. Eur Neuropsychopharmacol. 2002. PMID: 12468018 Review.
Cited by
-
In Quest of Pathognomonic/Endophenotypic Markers of Attention Deficit Hyperactivity Disorder (ADHD): Potential of EEG-Based Frequency Analysis and ERPs to Better Detect, Prevent and Manage ADHD.Med Devices (Auckl). 2020 May 22;13:115-137. doi: 10.2147/MDER.S241205. eCollection 2020. Med Devices (Auckl). 2020. PMID: 32547262 Free PMC article. Review.
-
Methylphenidate (MPH) promotes visual cortical activation in healthy adults in a cued visuomotor task.J Neural Transm (Vienna). 2012 Nov;119(11):1455-64. doi: 10.1007/s00702-012-0799-6. Epub 2012 Mar 30. J Neural Transm (Vienna). 2012. PMID: 22460297 Clinical Trial.
-
Electroencephalographic Correlates of Obsessive-Compulsive Disorder.Curr Top Behav Neurosci. 2021;49:169-199. doi: 10.1007/7854_2020_200. Curr Top Behav Neurosci. 2021. PMID: 33590459
-
Task preparation processes related to reward prediction precede those related to task-difficulty expectation.Neuroimage. 2014 Jan 1;84:639-47. doi: 10.1016/j.neuroimage.2013.09.039. Epub 2013 Sep 21. Neuroimage. 2014. PMID: 24064071 Free PMC article.
-
Volitional eye movement control and ADHD traits: a twin study.J Child Psychol Psychiatry. 2020 Dec;61(12):1309-1316. doi: 10.1111/jcpp.13210. Epub 2020 Feb 5. J Child Psychol Psychiatry. 2020. PMID: 32020616 Free PMC article.
References
-
- Arnsten AF, Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct. 2005;1(1):2. doi: 10.1186/1744-9081-1-2. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical